Search alternatives:
treatment increases » greater increases (Expand Search)
larger decrease » marked decrease (Expand Search)
significant a » significant _ (Expand Search), significant i (Expand Search), significant gap (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
treatment increases » greater increases (Expand Search)
larger decrease » marked decrease (Expand Search)
significant a » significant _ (Expand Search), significant i (Expand Search), significant gap (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
201
The hypoxia-treated ECs were incubated with bevacizumab, the VEGF-a inhibitor, and the expression of VEGF-a, HIF-1α, CD31 and α-SMA were detected.
Published 2022Subjects: “…inhibitor bevacizumab treatment…”
-
202
-
203
-
204
Illustrative MRI of a given patient at baseline and at the end of follow-up.
Published 2024Subjects: -
205
-
206
-
207
-
208
Statistically significant union pathways refer to the miRNAs with a decreased expression on day 5.
Published 2023“…<p>Statistically significant union pathways refer to the miRNAs with a decreased expression on day 5.…”
-
209
-
210
Statistically significant union pathways refer to the miRNAs with a decreased expression on day 1.
Published 2023“…<p>Statistically significant union pathways refer to the miRNAs with a decreased expression on day 1.…”
-
211
Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.
Published 2024Subjects: -
212
Scenario analysis for daratumumab using a cumulative cost-based price per year per vial.
Published 2024Subjects: -
213
Combination treatments increased p53 and decreased c-Myc levels in U-87MG and U-251MG cells more than did single treatments.
Published 2019“…<p>A-C: Western blot data showed that SLCP+BBR increased p53 and decreased c-Myc levels significantly more in U-87MG and U-251MG cells, in comparison to single treatments. …”
-
214
-
215
-
216
-
217
Obese ZSF1 male rats exhibited increased BW, glucose, insulin, cholesterol, and triglyceride levels and decreased adiponectin and increased GDF15 levels.
Published 2020“…<p>Obese ZSF1 male rats at the age of 20 weeks exhibited increased body weight (A), elevated blood glucose (B), insulin (C), cholesterol (D), and triglyceride levels (E), decreased adiponectin (F), and increased growth differentiation factor 15 (GDF15) (G). …”
-
218
-
219
-
220